FDA approves nasal spray to treat migraines, promising ‘efficacy on demand’
Low-cost sensors rapidly detect infections in wounds
9 September 2021Same-day discharge for hip and knee replacement surgery is safe and feasible in high-risk patients, study suggests
9 September 2021FDA approves nasal spray to treat migraines, promising ‘efficacy on demand’
Impel NeuroPharma, a Seattle-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration last week for its novel nasal spray that treats migraine headaches.
